Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether zolendronic acid, a third generation
bisphosphonate, is effective in preventing bone loss in the first year after kidney
transplantation.